Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Mellon

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Magnetic Resonance in Medicine|September 29, 2009
Detection of lactate with a hadamard slice selected, selective multiple quantum coherence, chemical shift imaging sequence (HDMD-SelMQC-CSI) on a clinical MRI scanner: Application to tumors and muscle ischemiaEric A Mellon, Seung-Cheol Lee, Stephen Pickup, et al.
Brachytherapy|November 7, 2016
Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomyEric A Mellon, Amber Orman, Luis E Joya, et al.
Journal of Gastrointestinal Oncology|August 27, 2016
Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancerEric A Mellon, Tobin J Strom, Sarah E Hoffe, et al.
Journal of Gastrointestinal Oncology|November 30, 2017
Outcomes of adjuvant radiotherapy and lymph node resection in elderly patients with pancreatic cancer treated with surgery and chemotherapyJessica Frakes, Eric A Mellon, Gregory M Springett, et al.
Acta Oncologica (Stockholm, Sweden)|March 4, 2015
Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinomaEric A Mellon, Sarah E Hoffe, Gregory M Springett, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
The Longitudinal Imaging Tracker (BrICS-LIT):A Cloud Platform for Monitoring Treatment Response in Glioblastoma PatientsKarthik Ramesh, Saumya S Gurbani, Eric A Mellon, et al.
Cancers|July 14, 2023
Spectroscopic MRI-Based Biomarkers Predict Survival for Newly Diagnosed Glioblastoma in a Clinical TrialAnuradha G Trivedi, Karthik K Ramesh, Vicki Huang, et al.
Cancers|September 28, 2021
Understanding the Radiobiology of Vestibular Schwannomas to Overcome Radiation ResistanceTorin P Thielhelm, Stefania Goncalves, Scott M Welford, et al.
Journal of Gastrointestinal Oncology|April 2, 2016
Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancerMichael D Chuong, Jessica M Frakes, Nicholas Figura, et al.
World Neurosurgery|June 6, 2024
Racial Disparities in Glioblastoma Genomic Alterations: A Comprehensive Analysis of a Multi-Institution Cohort of 2390 PatientsDanny John, Mohammed Alshalalfa, Timoteo Almeida, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Magnetic Resonance in Medicine|September 29, 2009
Detection of lactate with a hadamard slice selected, selective multiple quantum coherence, chemical shift imaging sequence (HDMD-SelMQC-CSI) on a clinical MRI scanner: Application to tumors and muscle ischemiaEric A Mellon, Seung-Cheol Lee, Stephen Pickup, et al.
Brachytherapy|November 7, 2016
Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomyEric A Mellon, Amber Orman, Luis E Joya, et al.
Journal of Gastrointestinal Oncology|August 27, 2016
Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancerEric A Mellon, Tobin J Strom, Sarah E Hoffe, et al.
Journal of Gastrointestinal Oncology|November 30, 2017
Outcomes of adjuvant radiotherapy and lymph node resection in elderly patients with pancreatic cancer treated with surgery and chemotherapyJessica Frakes, Eric A Mellon, Gregory M Springett, et al.
Acta Oncologica (Stockholm, Sweden)|March 4, 2015
Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinomaEric A Mellon, Sarah E Hoffe, Gregory M Springett, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
The Longitudinal Imaging Tracker (BrICS-LIT):A Cloud Platform for Monitoring Treatment Response in Glioblastoma PatientsKarthik Ramesh, Saumya S Gurbani, Eric A Mellon, et al.
Cancers|July 14, 2023
Spectroscopic MRI-Based Biomarkers Predict Survival for Newly Diagnosed Glioblastoma in a Clinical TrialAnuradha G Trivedi, Karthik K Ramesh, Vicki Huang, et al.
Cancers|September 28, 2021
Understanding the Radiobiology of Vestibular Schwannomas to Overcome Radiation ResistanceTorin P Thielhelm, Stefania Goncalves, Scott M Welford, et al.
Journal of Gastrointestinal Oncology|April 2, 2016
Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancerMichael D Chuong, Jessica M Frakes, Nicholas Figura, et al.
World Neurosurgery|June 6, 2024
Racial Disparities in Glioblastoma Genomic Alterations: A Comprehensive Analysis of a Multi-Institution Cohort of 2390 PatientsDanny John, Mohammed Alshalalfa, Timoteo Almeida, et al.
Pageof 8